Century Therapeutics, Inc. (IPSC)
Market Closed
17 Dec, 21:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 67
+0.04
+7.21%
$
46.47M Market Cap
- P/E Ratio
0% Div Yield
2,527,965 Volume
-2.04 Eps
$ 0.62
Previous Close Day Range
0.64 0.69
Year Range
0.34 1.19
Want to track IPSC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 84 days
Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade
Century Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 1 year ago
